1-Deoxynojirimycin
Model: MD05255
Category: Pharmaceutical and Medical Devices
Exhibitor: BIOSYNTH CARBOSYNTH
Booth No: N/A
Characteristic
Glucose analog and potent inhibitor of α-glucosidases of class I and II. It interferes with N-linked glycosylation and oligosaccharide processing. The compound inhibits intestinal α-glucosidase and has protective effects against obesity-induced hepatic injury as well as mitochondrial dysfunction. It also has neuroprotective effects since it reduces senescence-related cognitive impairment, neuroinflammation and amyloid beta deposition in mice.
Other Products
-
2-Deoxy-D-ribose
-
Octyl b-D-glucopyranoside
-
2'-Deoxy-5-ethynyluridine
-
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide HCl
-
2-Deoxy-D-glucose
-
3,4,6-Tri-O-acetyl-D-galactal
-
Methyl a-D-glucopyranoside
-
Isopropyl b-D-thiogalactopyranoside
-
2-Deoxy-2-fluoro-L-fucose
Highest Rated Products
-
ELMA 37kHz & 81kHz Ultrasonic Cleaner
-
JASCO HPLC
-
JASCO UV-Visible/NIR Spectrophotometer
-
Small Centrifuge
-
Analytik-Jena Crosslinker
-
EYELA Freeze Dryer
-
Constant Cell Disrupter
-
Benchmark Digital Incubators
-
EYELA Rotary Evaporator
-
JASCO Fourier Transform Infared Microscope
-
Levitronix® PuraLev® Low Shear Single-Use Pump Systems for Bioprocessing
-
ABLE Bioreactor
-
DSNK Expansion Kit
-
Human Male AB Serum
-
Biomaterials
-
OriCiro Cell-Free Cloning System
-
Boca Biolistics-Prospective collection/Clinical specimen
-
FOGACT Disinfection System
-
Preimplantation genetic testing (PGT)
-
B1240 Blister Containment Machine
-
Pexcite
-
Cartoner C 130
-
PTC 200 (New!)
-
Uhlmann Serialization Platform S 500
-
Blister line BEC 300
-
Rotavapor® R-300
-
cGMP Manufacturing
-
Rotavapor® R-100
-
Process Development
-
Analysis and Analytical Method Development
